(a) A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off-patent or generic drug.

(b) It is not a violation of subsection (a) of this section for a wholesale distributor to increase the price of an essential off-patent or generic drug if the price increase is directly attributable to additional costs for the drug imposed on the wholesale distributor by the manufacturer of the drug.